Amgen Inc (AMGN) stock
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3022% above fair value
$465.67−1.39 (-0.30%)
Close on Nov 13, 2026Market cap $251.76BP/E 27.0Yield 2.07%
Amgen gross margin
Gross margin is gross profit as a percentage of revenue.
Amgen's gross margin for the twelve months ending Sep 30, 2026 was 70.9%. For fiscal 2025 it was 67.2%, against 61.5% the year before. The highest annual figure on record is 82.7% in fiscal 2018.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 67.2% | +5.7 |
| FY2024 | Dec 31, 2024 | 61.5% | −8.5 |
| FY2023 | Dec 31, 2023 | 70.0% | −5.6 |
| FY2022 | Dec 31, 2022 | 75.7% | +0.5 |
| FY2021 | Dec 31, 2021 | 75.2% | −0.6 |
| FY2020 | Dec 31, 2020 | 75.8% | −5.6 |
| FY2019 | Dec 31, 2019 | 81.4% | −1.4 |
| FY2018 | Dec 31, 2018 | 82.7% | +0.5 |
| FY2017 | Dec 31, 2017 | 82.2% | +0.3 |
| FY2016 | Dec 31, 2016 | 81.9% | +1.4 |
| FY2015 | Dec 31, 2015 | 80.5% | +2.5 |
| FY2014 | Dec 31, 2014 | 78.0% | −4.1 |
| FY2013 | Dec 31, 2013 | 82.1% | +0.6 |
| FY2012 | Dec 31, 2012 | 81.5% | −1.1 |
| FY2011 | Dec 31, 2011 | 82.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 73.1% | +5.4 |
| Q2 FY2026 | Jun 30, 2026 | 72.0% | +4.8 |
| Q1 FY2026 | Mar 31, 2026 | 68.2% | +4.6 |
| Q4 FY2025 | Dec 31, 2025 | 69.8% | +4.1 |
| Q3 FY2025 | Sep 30, 2025 | 67.8% | +6.7 |
| Q2 FY2025 | Jun 30, 2025 | 67.2% | +5.8 |
| Q1 FY2025 | Mar 31, 2025 | 63.6% | +6.5 |
| Q4 FY2024 | Dec 31, 2024 | 65.7% | +3.7 |
| Q3 FY2024 | Sep 30, 2024 | 61.1% | −12.8 |
| Q2 FY2024 | Jun 30, 2024 | 61.4% | −12.6 |
| Q1 FY2024 | Mar 31, 2024 | 57.0% | −14.8 |
| Q4 FY2023 | Dec 31, 2023 | 62.0% | −12.4 |
| Q3 FY2023 | Sep 30, 2023 | 73.8% | −2.3 |
| Q2 FY2023 | Jun 30, 2023 | 74.0% | −3.1 |
| Q1 FY2023 | Mar 31, 2023 | 71.8% | −3.1 |
| Q4 FY2022 | Dec 31, 2022 | 74.5% | −0.4 |
| Q3 FY2022 | Sep 30, 2022 | 76.1% | +1.4 |
| Q2 FY2022 | Jun 30, 2022 | 77.1% | +5.7 |
| Q1 FY2022 | Mar 31, 2022 | 75.0% | +4.2 |
| Q4 FY2021 | Dec 31, 2021 | 74.9% | +3.7 |
| Q1 FY2021 | Mar 31, 2021 | 74.8% | +3.6 |
| Q4 FY2020 | Dec 31, 2020 | 71.4% | −6.3 |
| Q3 FY2020 | Sep 30, 2020 | 70.7% | −5.4 |
| Q2 FY2020 | Jun 30, 2020 | 71.2% | −7.5 |
| Q1 FY2020 | Mar 31, 2020 | 71.1% | −4.7 |
| Q2 FY2019 | Jun 30, 2019 | 77.7% | +0.9 |
| Q1 FY2019 | Mar 31, 2019 | 76.1% | −3.1 |
| Q4 FY2018 | Dec 31, 2018 | 78.7% | −2.3 |
| Q3 FY2018 | Sep 30, 2018 | 75.8% | −1.5 |
| Q2 FY2018 | Jun 30, 2018 | 76.8% | −1.5 |
| Q1 FY2018 | Mar 31, 2018 | 79.2% | +2.3 |
| Q4 FY2017 | Dec 31, 2017 | 81.0% | −0.2 |
| Q3 FY2017 | Sep 30, 2017 | 77.3% | −4.1 |
| Q2 FY2017 | Jun 30, 2017 | 78.3% | −2.5 |
| Q1 FY2017 | Mar 31, 2017 | 76.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 81.2% | – |
| Q3 FY2016 | Sep 30, 2016 | 81.4% | – |
| Q2 FY2016 | Jun 30, 2016 | 80.8% | – |
See a number that looks wrong?